International Myeloma Foundation Responds to ICER Report

The International Myeloma Foundation (IMF) recently spoke out against the Institute for Clinical and Economic Review’s (ICER) report on the value of myeloma drugs. Find out what IMF had to say here. (Source: Journal of Clinical Pathways, 5/26/16)

You might also be interested in:

Value-based Analysis of Telehealth in the US 11/24/2021
Course Available: Introduction to Health Economics and… 02/09/2022
Real-World Evidence 2022: Rare Diseases and Innovative Therapies 02/15/2022
Evidence Partners and Clarivate Form Channel Partnership to… 02/01/2022
Influential Usage of Big Data and Artificial Intelligence in… 09/07/2021
Tufts Medical Center and National Health Council Report New… 05/25/2021
ICER Meets With FDA, EMA, and FDA to Discuss RWE Procedures 10/12/2021